Cspc Pharmaceutical Group Ltd ADR (CSPCY)

$3.94 -0.08 (-1.98%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 400
Avg Vol 4,322
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 16%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idio...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 86 311 8703 7015
Fax: 86 311 8703 9608
Address:
No.896 Zhongshandong Street, Gaoxin District, Shijiazhuang, China
WAYWARD_SUN
WAYWARD_SUN Apr. 10 at 8:36 PM
$CSPCY
0 · Reply
value420
value420 Feb. 15 at 4:32 PM
$CSPCY
0 · Reply
AlwaysRational
AlwaysRational Dec. 9 at 11:23 PM
$YI Here's an interesting interview with Steve Alain Lawrence from CNBC, CIO at Balfour Capital. He has some interesting things to say about value in the pharma industry in China, starting at 1:16. https://www.youtube.com/watch?v=OJwfEkDDk7c Of note: YI has been running with $CSPCY as of late.
0 · Reply
arrotrader
arrotrader Oct. 7 at 12:10 PM
$CSPCY 2bn$ licensing agreement with AZ... exponential increase in watchers coming? lol
0 · Reply
fda_tracker
fda_tracker Sep. 6 at 1:05 PM
$CSPCY Phase 3 trial w/est Sep completion date NCT05753865: https://www.clinicaltrials.gov/study/NCT05753865 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
fda_tracker
fda_tracker Aug. 9 at 1:05 PM
$CSPCY Phase 2 trial w/est Aug completion date NCT06220097: https://www.clinicaltrials.gov/study/NCT06220097 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
fda_tracker
fda_tracker Aug. 8 at 1:05 PM
$CSPCY Phase 2 trial w/est Aug completion date NCT04826107: https://www.clinicaltrials.gov/study/NCT04826107 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
fda_tracker
fda_tracker Mar. 12 at 1:05 PM
$CSPCY Phase 2 trial w/est Mar completion date NCT05863325: https://www.clinicaltrials.gov/study/NCT05863325 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
value420
value420 Feb. 21 at 5:32 PM
$CSPCY
0 · Reply
fda_tracker
fda_tracker Feb. 8 at 2:05 PM
$CSPCY Phase 2 trial w/est Feb completion date NCT05475717: https://www.clinicaltrials.gov/study/NCT05475717 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
Latest News on CSPCY
No data available.
WAYWARD_SUN
WAYWARD_SUN Apr. 10 at 8:36 PM
$CSPCY
0 · Reply
value420
value420 Feb. 15 at 4:32 PM
$CSPCY
0 · Reply
AlwaysRational
AlwaysRational Dec. 9 at 11:23 PM
$YI Here's an interesting interview with Steve Alain Lawrence from CNBC, CIO at Balfour Capital. He has some interesting things to say about value in the pharma industry in China, starting at 1:16. https://www.youtube.com/watch?v=OJwfEkDDk7c Of note: YI has been running with $CSPCY as of late.
0 · Reply
arrotrader
arrotrader Oct. 7 at 12:10 PM
$CSPCY 2bn$ licensing agreement with AZ... exponential increase in watchers coming? lol
0 · Reply
fda_tracker
fda_tracker Sep. 6 at 1:05 PM
$CSPCY Phase 3 trial w/est Sep completion date NCT05753865: https://www.clinicaltrials.gov/study/NCT05753865 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
fda_tracker
fda_tracker Aug. 9 at 1:05 PM
$CSPCY Phase 2 trial w/est Aug completion date NCT06220097: https://www.clinicaltrials.gov/study/NCT06220097 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
fda_tracker
fda_tracker Aug. 8 at 1:05 PM
$CSPCY Phase 2 trial w/est Aug completion date NCT04826107: https://www.clinicaltrials.gov/study/NCT04826107 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
fda_tracker
fda_tracker Mar. 12 at 1:05 PM
$CSPCY Phase 2 trial w/est Mar completion date NCT05863325: https://www.clinicaltrials.gov/study/NCT05863325 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
value420
value420 Feb. 21 at 5:32 PM
$CSPCY
0 · Reply
fda_tracker
fda_tracker Feb. 8 at 2:05 PM
$CSPCY Phase 2 trial w/est Feb completion date NCT05475717: https://www.clinicaltrials.gov/study/NCT05475717 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
EarningsInsider
EarningsInsider Jan. 25 at 2:40 PM
CSPC Pharmaceutical Group Sees Short Interest Decrease from 6,000 shares to 2,200 shares. $CSPCY https://www.marketbeat.com/stocks/OTCMKTS/
0 · Reply
EarningsInsider
EarningsInsider Jan. 11 at 3:14 PM
CSPC Pharmaceutical Group Sees Short Interest Decrease from 17,600 shares to 6,000 shares. $CSPCY https://www.marketbeat.com/stocks/OTCMKTS
0 · Reply
ACsovereigntony
ACsovereigntony Oct. 24 at 1:40 PM
$CSPCY sold my position for 5% ROI. GLTA.
0 · Reply
fda_tracker
fda_tracker Oct. 20 at 1:05 PM
$CSPCY Phase 2 trial w/est Oct completion date NCT05117658: https://www.clinicaltrials.gov/study/NCT05117658 Trial Tracker: https://www.fdatracker.com/trial-tracker/
0 · Reply
ACsovereigntony
ACsovereigntony Oct. 19 at 3:34 PM
$CSPCY bought more shares at 2.77
0 · Reply
ACsovereigntony
ACsovereigntony Oct. 18 at 7:10 PM
$CSPCY I'm back in at 2.80
0 · Reply
ACsovereigntony
ACsovereigntony Oct. 6 at 7:46 PM
$CSPCY sold my position for 2% ROI. Quick trade for me. Will keep an eye on to see if it re-test the all time low on a day when the major indexes are down at least 1%. GLTA.
0 · Reply
ACsovereigntony
ACsovereigntony Oct. 5 at 7:08 PM
$CSPCY I'm back in at 2.66
0 · Reply
ACsovereigntony
ACsovereigntony Aug. 25 at 3:53 PM
$CSPCY sold my position for 3% ROI. Will keep an eye on to see if it pulls back. GLTA.
0 · Reply
ACsovereigntony
ACsovereigntony Aug. 21 at 3:07 PM
$CSPCY bought more shares at 2.79
0 · Reply